We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Public health advice for managing cases of mpox in prisons and other prescribed places of detention.
Resource page for the national point prevalence survey (PPS) on healthcare-associated infections (HCAIs), antimicrobial use (AMU) and antimicrobial stewardship (AMS) in England, 2023.
An explanation of how UKHSA processes your personal data when you apply to access it for secondary purposes
Privacy notice for patients participating in surgical site infection surveillance.
Culex modestus is a bridge vector for West Nile Virus and is associated with wetland habitats.
The administration of meningococcal B vaccine for the prevention of gonorrhoea in eligible gay, bisexual, and men who have sex with men (GBMSM).
Information on exposure to radio signals from 5G technologies.
Information about acrylamide for use in responding to chemical incidents.
Template letter to communicate with parents whose babies missed BCG immunisation.
Information on benzo(a)pyrene (BaP), an indicator species for polycyclic aromatic hydrocarbons (PAHs), for use in responding to chemical incidents.
Advice for people who inject drugs (PWID) on reducing the risk of wound botulism.
Algorithm for GPs, emergency physicians and other medical professionals in England to diagnose and manage CO poisoning in patients.
British Sign Language (BSL) videos on COVID-19 vaccination.
Information for healthcare professionals on myocarditis and pericarditis following COVID-19 vaccination.
Leaflet for people eligible for COVID-19 vaccination who have had their first dose of AstraZeneca vaccine and have concerns about having the second dose.
How to classify and manage people who have been exposed to CCHF.
Information on diesel, for use in responding to chemical incidents.
Information for healthcare professionals on diphtheria anti-toxin (DAT).
Information on the reasons behind human infectious disease emergence, including a timeline and a global map.
Explanation of the personal information collected as part of UKHSA's enhanced Yersinia surveillance, how we use it and who we share it with.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).